Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenichi Suda

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2023
Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 InsertionAkira Hamada, Kenichi Suda, Masaya Nishino, et al.
JTCVS Open|July 10, 2023
Prognostic role of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography with an image-based harmonization technique: A multicenter retrospective studyAkira Hamada, Kazuhiro Kitajima, Kenichi Suda, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 21, 2025
Similar Trend in Benefit of Adjuvant Platinum in Lung Cancer Patients Irrespective of Epidermal Growth Factor Receptor Mutation StatusKenichi Suda, Kosuke Fujino, Mao Yoshikawa, et al.
The Annals of Thoracic Surgery|July 3, 2020
Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer CasesKenichi Suda, Tetsuya Mitsudomi, Yasushi Shintani, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expressionShengxiang Ren, Qinrui Tian, Nadav Amar, et al.
Clinical Lung Cancer|August 28, 2018
A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell LinesShengxiang Ren, Christopher J Rivard, Hui Yu, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2025
Clinical utility of the 5-point visual Deauville score for preoperative evaluation in stage I non-small cell lung cancer: A multicenter retrospective studyTomoyo Fukami, Akira Hamada, Kenichi Suda, et al.
Translational Lung Cancer Research|June 13, 2022
Clinical characteristics, surgical treatments, prognosis, and prognostic factors of primary tracheal cancer patients: 20-year data of the National Cancer Center, ChinaJiagen Li, Fengwei Tan, Yalong Wang, et al.
International Journal of Cancer|November 21, 2024
Prognostic impact of PD-L1 expression in surgically resected EGFR-mutant lung adenocarcinoma: A real-world database study in Japan (CReGYT-01 EGFR study)Kotaro Nomura, Kazuki Takada, Fumihiko Kinoshita, et al.
Clinical Lung Cancer|January 17, 2025
Prognostic Analysis of Pathological Stage I Lung Adenocarcinoma Harboring Major EGFR MutationsShinkichi Takamori, Makoto Endo, Akira Hamada, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2023
Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 InsertionAkira Hamada, Kenichi Suda, Masaya Nishino, et al.
JTCVS Open|July 10, 2023
Prognostic role of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography with an image-based harmonization technique: A multicenter retrospective studyAkira Hamada, Kazuhiro Kitajima, Kenichi Suda, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 21, 2025
Similar Trend in Benefit of Adjuvant Platinum in Lung Cancer Patients Irrespective of Epidermal Growth Factor Receptor Mutation StatusKenichi Suda, Kosuke Fujino, Mao Yoshikawa, et al.
The Annals of Thoracic Surgery|July 3, 2020
Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer CasesKenichi Suda, Tetsuya Mitsudomi, Yasushi Shintani, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expressionShengxiang Ren, Qinrui Tian, Nadav Amar, et al.
Clinical Lung Cancer|August 28, 2018
A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell LinesShengxiang Ren, Christopher J Rivard, Hui Yu, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2025
Clinical utility of the 5-point visual Deauville score for preoperative evaluation in stage I non-small cell lung cancer: A multicenter retrospective studyTomoyo Fukami, Akira Hamada, Kenichi Suda, et al.
Translational Lung Cancer Research|June 13, 2022
Clinical characteristics, surgical treatments, prognosis, and prognostic factors of primary tracheal cancer patients: 20-year data of the National Cancer Center, ChinaJiagen Li, Fengwei Tan, Yalong Wang, et al.
International Journal of Cancer|November 21, 2024
Prognostic impact of PD-L1 expression in surgically resected EGFR-mutant lung adenocarcinoma: A real-world database study in Japan (CReGYT-01 EGFR study)Kotaro Nomura, Kazuki Takada, Fumihiko Kinoshita, et al.
Clinical Lung Cancer|January 17, 2025
Prognostic Analysis of Pathological Stage I Lung Adenocarcinoma Harboring Major EGFR MutationsShinkichi Takamori, Makoto Endo, Akira Hamada, et al.
Pageof 13